China Emerges as a Global Biopharma Innovation Hub
China has shifted from manufacturing base to biopharma innovation hub, with cross-border deal structures evolving fast, according to a new JD Supra analysis.
Topic
Cross Border Deals
Topic
Topic
Topic
China has shifted from manufacturing base to biopharma innovation hub, with cross-border deal structures evolving fast, according to a new JD Supra analysis.